We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.56T
1-Year Est. Return 27.86%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+4.96%
1 Year Est. Return
+27.86%
3 Year Est. Return
+90.49%
5 Year Est. Return
+115.47%
10 Year Est. Return
+472.96%
AUM
$453B
AUM Growth
+$15.7B
Cap. Flow
-$4.06B
Cap. Flow %
-0.9%
Top 10 Hldgs %
18.01%
Holding
5,458
New
502
Increased
2,053
Reduced
1,909
Closed
470

Sector Composition

Rank Sector Weight
1 Financials 14.34%
2 Technology 11.83%
3 Healthcare 9.48%
4 Consumer Discretionary 7.99%
5 Industrials 7.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AKCA
4176
DELISTED
Akcea Therapeutics Inc
AKCA
$74K ﹤0.01%
+2,619
New +$48.5K
ALT icon
4177
Altimmune
ALT
$593M
$73K ﹤0.01%
+1,047
New +$77.9K
ECHO
4178
EchoStar
ECHO
$25.9B
$73K ﹤0.01%
+1,567
New +$74.7K
SO icon
4179
PUT
Southern Company
SO
$105B
$73K ﹤0.01%
+1,500
New +$72.7K
ECYT
4180
DELISTED
Endocyte, Inc. Common Stock
ECYT
$73K ﹤0.01%
53,778
-188,688
-78% -$263K
NW.PRC.CL
4181
DELISTED
Natwest Bank Ads Series C
NW.PRC.CL
$73K ﹤0.01%
+2,880
New +$74.5K
CLMT icon
4182
Calumet Specialty Products
CLMT
$3.96B
$72K ﹤0.01%
8,838
-27,162
-75% -$169K
FPH icon
4183
Five Point Holdings
FPH
$376M
$72K ﹤0.01%
5,337
-4,398
-45% -$62.1K
PSLV icon
4184
Sprott Physical Silver Trust
PSLV
$13.7B
$71K ﹤0.01%
11,214
RBA icon
4185
RB Global
RBA
$17.4B
$71K ﹤0.01%
2,283
+350
+18% +$10.1K
ICD
4186
DELISTED
Independence Contract Drilling, Inc.
ICD
$71K ﹤0.01%
936
+871
+1,340% +$61.6K
AFMD
4187
DELISTED
Affimed
AFMD
$70K ﹤0.01%
+3,330
New +$72.1K
CCJ icon
4188
Cameco
CCJ
$42.4B
$70K ﹤0.01%
7,042
-1,260
-15% -$12.5K
LXFR icon
4189
Luxfer Holdings
LXFR
$457M
$70K ﹤0.01%
5,651
+3,251
+135% +$40.5K
NVEE
4190
DELISTED
NV5 Global
NVEE
$70K ﹤0.01%
+5,168
New +$58.5K
PPBI
4191
DELISTED
Pacific Premier Bancorp
PPBI
$70K ﹤0.01%
1,859
-45,956
-96% -$1.65M
VRA icon
4192
Vera Bradley
VRA
$96.4M
$70K ﹤0.01%
8,138
+1,165
+17% +$10.9K
MTEM
4193
DELISTED
Molecular Templates, Inc.
MTEM
$70K ﹤0.01%
+724
New +$62.5K
BREW
4194
DELISTED
Craft Brew Alliance, Inc.
BREW
$70K ﹤0.01%
+3,886
New +$68.9K
APPS icon
4195
Digital Turbine
APPS
$1.74B
$69K ﹤0.01%
+47,480
New +$56.1K
GORO icon
4196
Goldgroup Mining Inc.
GORO
$186M
$69K ﹤0.01%
18,167
-88,180
-83% -$343K
ITM icon
4197
VanEck Intermediate Muni ETF
ITM
$2.13B
$69K ﹤0.01%
1,439
IXN icon
4198
iShares Global Tech ETF
IXN
$9.17B
$69K ﹤0.01%
2,946
+540
+22% +$12.4K
NCSM icon
4199
NCS Multistage Holdings
NCSM
$132M
$69K ﹤0.01%
+144
New +$63.1K
BCLI
4200
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$68K ﹤0.01%
+1,106
New +$71.6K

Similar funds

JP Morgan Chase's Q3 2017 Portfolio in Review

As of Q3 2017, JP Morgan Chase held 5,458 positions worth $453B, up 3.6% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

JP Morgan Chase's Q3 2017 filing shows 502 new, 2,053 increased, 1,909 reduced and 470 closed positions. Its largest new stake was JBG SMITH: 3,403,127 shares worth $116M. The largest sale was Du Pont De Nemours E I, an estimated $1.4B.

By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.

  • JP Morgan Chase's largest Q3 2017 buy was JBG SMITH: 3,403,127 shares worth $116M.
  • JP Morgan Chase added most to DuPont de Nemours in Q3 2017, an estimated $1.51B increase.
  • JP Morgan Chase's biggest Q3 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $727M.
  • JP Morgan Chase fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.4B.
  • JP Morgan Chase's ten largest holdings make up 18% of its $453B portfolio in Q3 2017.
  • JP Morgan Chase opened 502 new positions and closed 470 in Q3 2017.
  • JP Morgan Chase's portfolio value rose 3.6% quarter-over-quarter to $453B.

Based on JP Morgan Chase's 13F filing for Q3 2017, filed 9 Nov 2017.